Procedural closure of the patent ductus arteriosus in preterm infants: a clinical practice guideline
- PMID: 38997403
- DOI: 10.1038/s41372-024-02052-9
Procedural closure of the patent ductus arteriosus in preterm infants: a clinical practice guideline
Abstract
Importance: Transcatheter closure of the patent ductus arteriosus (PDA) is being increasingly adopted as an alternative to surgical PDA closure in preterm infants.
Objective: To develop rigorous clinical practice guideline recommendations on procedural PDA closure in preterm infants.
Methods: The principles of the GRADE (Grading of Recommendations Assessment, Development and Evaluation) Evidence-to-Decision (EtD) framework were used to develop the guideline recommendations. An e-Delphi survey of 45 experts was conducted and recommendations that reached ≥75% agreement were accepted as consensus.
Main recommendations: Procedural PDA closure may be considered in extremely preterm infants (<28 weeks gestational age) requiring invasive mechanical ventilation >10 postnatal days and confirmed to have a large hemodynamically significant PDA, at centers with high local rates of death and/or bronchopulmonary dysplasia (conditional recommendation). If sufficient institutional expertise is available and patient characteristics are suitable, transcatheter PDA closure may be considered as the preferred approach over PDA ligation (conditional recommendation).
© 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.
References
-
- Benitz WE, Committee on Fetus and Newborn, American Academy of Pediatrics. Patent ductus arteriosus in preterm infants. Pediatrics. 2016;137:e20153730.
-
- Mitra S, de Boode WP, Weisz DE, Shah PS. Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of cochrane systematic reviews. Cochrane Database Syst Rev. 2023;4:CD013588. - PubMed
-
- Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database Syst Rev. 2020;11:CD003481.
-
- Evans P, O’Reilly D, Flyer JN, Soll R, Mitra S. Indomethacin for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. 2021;1:CD013133.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources